Literature DB >> 6282185

Sympathetic control of renin release.

J Torretti.   

Abstract

Sympathetic outflow influences the renal release of renin through modifications of the tonic activity of the renal nerves and the plasma concentration of catecholamines. These influences may initiate changes in the rate of renin secretion or modulate the response initiated by another of the mechanisms that control renin release. Beta-adrenoceptor mediated stimulation of renin release has been demonstrated in vivo, in the isolated perfused kidney and in preparation in vitro. Likewise an array of evidence has accumulated pointing to the existence of alpha-adrenoceptor mediated inhibition of renin release. However, the cellular location, the physiological significance, and even the existence of these alpha-adrenoceptors is still disputed. Receptors sensitive to alterations in the vascular volume have been identified in areas of low and high pressure of the circulation. There is evidence that input from both types of receptors may cancel each other, and that to demonstrate experimentally the effects on renin release of the low pressure cardiopulmonary receptors it is necessary to avoid changes in the input from the high pressure arterial receptors, and vice versa. Again there are dissenting voices that disclaim a tonic inhibitory effect of cardiopulmonary receptor initiated impulses on renin release. The majority of the pharmacological evidence identifies the beta-adrenoceptors in JG cells as of the beta 1-subtype. However, some species may make exception to this generalization. As in other tissues, beta-adrenoceptor mediated influences appear to relate to activation of adenylcyclase in the cell membrane. Considerable interest in the role of calcium in the process of activation of renin release has met with some unexpected, though consistent, experimental findings.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282185     DOI: 10.1146/annurev.pa.22.040182.001123

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  6 in total

Review 1.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

3.  Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism.

Authors:  N Fukuda; M Soma; A Kubo; M Kunimoto; Y Watanabe; Y Izumi; K Kanmatsuse
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

4.  Mechanism of effect of dibutyryl cyclic adenosine 3',5'-monophosphate on canine renal renin release.

Authors:  N Bondar; P Cadnapaphornchai; F D McDonald; S Taher
Journal:  J Physiol       Date:  1984-10       Impact factor: 5.182

5.  Plasma renin activity, aldosterone and catecholamine levels when swimming and running.

Authors:  C Y Guezennec; G Defer; G Cazorla; C Sabathier; F Lhoste
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

Review 6.  The NLRP3 Inflammasome Role in the Pathogenesis of Pregnancy Induced Hypertension and Preeclampsia.

Authors:  Maciej W Socha; Bartosz Malinowski; Oskar Puk; Mariusz Dubiel; Michał Wiciński
Journal:  Cells       Date:  2020-07-08       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.